In vivo Evaluation and in silico Prediction of the Toxicity of Drepanoalpha Hard capsules
Authors:
- Benjamin Gbolo ZoaweBZBenjamin Gbolo Zoawe
- Jean-Paul Ngbolua Koto-Te-NyiwaJKJean-Paul Ngbolua Koto-Te-Nyiwa
- Damien Tshibangu Sha-TshibeyDSDamien Tshibangu Sha-Tshibey
- Patrick Memvanga BondoPBPatrick Memvanga Bondo
- Dorothee Tshilanda DinangayiDDDorothee Tshilanda Dinangayi
- Aristote MatondoAMAristote Matondo
- Jason Kilembe ThambweJTJason Kilembe Thambwe
- Bienvenu Lebwaze MasambaBMBienvenu Lebwaze Masamba
- Amandine NachtergaelANAmandine Nachtergael
- Pius Mpiana TshimankindaPTPius Mpiana Tshimankinda
- Pierre DuezPDPierre Duez
Preprint
Abstract
This study was carried out in order to investigate the safety of Drepanoalpha hard hard capsules, a phytomedicine used for the management of sickle cell disease in the Democratic Republic of Congo by the acute and sub-acute administration in Guinea pigs. The hard capsules were dissolved in saline normal solution (NaCl 0.9 %). The animals were randomly selected, marked and divided into 2 groups of 5 animals each (3 males and 2 females) for acute toxicity and 4 groups of 3 animals each for sub-acute toxicity. Those received by gavage a single dose of 5000 mg/kg body weight (B.W.) of Drepanoalpha hard capsules for acute toxicity followed by 125 mg/Kg, 250 mg/Kg and 500 mg/Kg B.W. twice daily for 28 days for sub-acute toxicity and saline normal solution (NaCl 0.9 % solution as vehicle). Hematological, biochemical and histopathological analyses were performed and the behavior of the animals was observed after treatment. The results showed that 50 % of the lethal dose (LD50) is greater than 5000 mg/Kg B.W., and the relative weights of vital organs (kidney, liver, lungs, and heart) collected from Guinea pigs at the end of treatment on D14 (acute toxicity) and D28 (sub-acute toxicity) did not undergone significant changes (p>0.05). The results of haematological (Red Blood Cells, White Blood Cells, Haemoglobin, Haematocrit) and biochemical (ALT, AST, Albumin, Total Protein) tests did not show significant differences between the control and test groups at significance level (0.05 for acute toxicity), while the histopathological study revealed none damage to the various organs excised. In conclusion, the results confirm the safety of Drepanoalpha, as shown in previous studies with lyophilisate and decocate in rats and Guinea pigs.Keywords
This publication has 31 references indexed in Scilit:
- Potential anti-inflammatory phenolic glycosides from the medicinal plant Moringa oleifera fruitsBioorganic & Medicinal Chemistry, 2010
- Subacute toxicological evaluation ofAsiasari radixmethanol extractDrug and Chemical Toxicology, 2009
- Acute Oral Toxicity Evaluation of Some Polyherbal Formulations in Albino Wistar RatsInternational Journal of Pharmacology, 2008
- In vitro Antisickling Activity of Anthocyanins Extract of a Congolese Plant: Alchornea cordifolia M. Arg.Journal of Medical Sciences, 2007
- In vitro Antisickling Activity of Anthocyanins from Ocimum basilicum L. (Lamiaceae)International Journal of Pharmacology, 2007
- Acute and chronic toxicity of the aqueous extract of Artemisia afra in rodentsJournal of Ethnopharmacology, 2007
- Preliminary toxicity and phytochemical studies of the stem bark aqueous extract of Musanga cecropioides in ratsJournal of Ethnopharmacology, 2006
- Drug Metabolism and Variability among Patients in Drug ResponseNew England Journal of Medicine, 2005
- Evaluation of Abnormal Liver-Enzyme Results in Asymptomatic PatientsNew England Journal of Medicine, 2000
- Niaziminin, a Thiocarbamate from the Leaves ofMoringa oleifera, Holds a Strict Structural Requirement for Inhibition of Tumor-Promoter-Induced Epstein-Barr Virus ActivationPlanta Medica, 1998